Better Robotics Stock: UiPath or Zebra Technologies
Zebra Technology's stock is up more than 11% this year. UiPath has shown it can be profitable.
PATH - UiPath Inc.
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$13.20
DETAILS
HIGH:
$15.00
LOW:
$12.00
MEDIAN:
$13.00
CONSENSUS:
$13.20
UPSIDE:
10.46%
Stock News
UiPath: The Odds Of Agentic AI Are Not Priced In
UiPath is rated a buy at $12, trading at 15x FY2027 and 13x FY2028 earnings, with strong 80%+ gross margins. Revenue grew 17% to $418M in Q1 FY2027, ARR rose 12% to $1.9B, and non-GAAP operating margin reached 22%. Agentic automation (Maestro) is UiPath's key catalyst, but AI monetization is unproven; net retention at 109% needs to improve for higher growth.
Squeeze Watch: 10 Stocks Bears Love to Hate Most Right Now
Short‑interest screens are lighting up with a tight cluster of mid‑ and large‑cap names where bearish bets have gone all‑in, turning these stocks into live‑wire squeeze candidates rather than sleepy laggards.
Is UiPath's 6-Month Pullback Creating an Investment Opportunity?
PATH's six-month pullback comes as AI adoption, enterprise customer growth and profitability improve, creating a more attractive entry point.
Why UiPath (PATH) is a Top Momentum Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
UiPath (PATH) Stock Declines While Market Improves: Some Information for Investors
In the closing of the recent trading day, UiPath (PATH) stood at $11.68, denoting a -1.02% move from the preceding trading day.
UiPath's Valuation Looks Attractive After the Recent Pullback
PATH's pullback has lowered its valuation as improving profitability, ARR growth and an upbeat outlook strengthen the long-term investment case.
Here's Why UiPath (PATH) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
3 Better Moonshot Stocks to Buy Instead of SpaceX
IonQ is a leader in the race toward accurate quantum computing. SoundHound AI's acquisition of LivePerson could be a game changer.
UiPath, Inc. (PATH) Is a Trending Stock: Facts to Know Before Betting on It
Zacks.com users have recently been watching UiPath (PATH) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Stock Market Today, July 2: UiPath Gains as Agentic Automation Strategy Faces Earnings Test
Expand NYSE: PATH UiPath Today's Change (1.08%) $0.13 Current Price $11.68 Key Data Points Market Cap $6.0B Day's Range $11.30 - $11.77 52wk Range $9.20 - $19.84 Volume 1M Avg Vol 38.7M Gross Margin 82.71% UiPath (PATH +1.08%), an agentic automation software platform, closed at $11.69, up 1.21%. The stock was tracking its automation story in premarket trading, and investors are watching the next earnings date as the near-term catalyst.
UiPath Broadens Enterprise Automation Ambitions With Maestro Case
PATH's Maestro Case launch expands its reach into complex enterprise workflows, deepening its push beyond traditional automation.
UiPath vs. Nu Holdings: Which Disruptive Growth Stock is a Buy?
PATH's AI orchestration push and growing enterprise adoption make it a more compelling buy over NU despite Nubank's strong fintech growth.
Investors Heavily Search UiPath, Inc. (PATH): Here is What You Need to Know
Zacks.com users have recently been watching UiPath (PATH) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Stock Market Today, June 22: UiPath Falls as Agentic Automation Push Faces ARR Growth Test
Expand NYSE: PATH UiPath Today's Change (-1.22%) $-0.13 Current Price $10.14 Key Data Points Market Cap $5.3B Day's Range $10.01 - $10.52 52wk Range $9.20 - $19.84 Volume 916.9K Avg Vol 33.1M Gross Margin 82.71% UiPath (PATH 1.22%), an enterprise automation software provider, closed at $10.15, down 1.07%. UiPath traded lower despite the recent launch of Maestro Case, as investors continued to weigh its agentic automation push against the need for stronger ARR growth.
Why UiPath (PATH) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
UiPath's Agentic AI Adoption Continues to Gain Momentum
PATH is seeing agentic AI move from pilot projects to production deployments, strengthening demand for its automation platform.
UiPath Introduces Maestro Case to Orchestrate Dynamic, Exception-Heavy Business Processes Across the Enterprise
NEW YORK--(BUSINESS WIRE)--UiPath, Inc. announces Maestro Case, a new AI-native UiPath agentic case management capability.
How Much Upside is Left in UiPath (PATH)? Wall Street Analysts Think 25.21%
The mean of analysts' price targets for UiPath (PATH) points to a 25.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
UiPath, Inc. (PATH) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching UiPath (PATH) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Price Targets
UiPath price target lowered to $12 from $13 at UBS
$12.00
(was $10.78)
UBS
UiPath price target lowered to $13 from $14 at BMO Capital
$13.00
(was $12.82)
New Street
UiPath Inc. (PATH) PT Lowered to $12 at DA Davidson as Growth 'Adequately Priced in'
$12.00
(was $11.60)
Lucky Schreiner
·
D.A. Davidson
Needham Upgrades UiPath Inc. (PATH) to Buy 'on NN ARR Growth, FCF Growth'
$15.00
(was $12.38)
Scott Berg
·
Needham
UiPath Inc. (PATH) PT Lowered to $13 at UBS
$13.00
(was $12.38)
Radi Sultan
·
UBS
UiPath price target lowered to $14 from $17 at RBC Capital
$14.00
(was $12.95)
RBC Capital
UiPath price target raised to $18 from $16 at Barclays
$18.00
(was $16.32)
Barclays
UiPath price target lowered to $17 from $19 at RBC Capital
$17.00
(was $15.88)
RBC Capital
UiPath Inc. (PATH) PT Raised to $19 at RBC Capital
$19.00
(was $18.40)
Matthew Hedberg
·
RBC Capital
UiPath price target raised to $19 from $15 at Morgan Stanley
$19.00
(was $19.35)
Sanjit Singh
·
Morgan Stanley
UiPath price target raised to $17 from $12 at Truist
$17.00
(was $18.45)
Truist Financial
UiPath price target raised to $17 from $13 at BMO Capital
$17.00
(was $18.43)
Keith Bachman
·
BMO Capital
UiPath Inc. (PATH) PT Raised to $15 at DA Davidson
$15.00
(was $18.34)
Lucky Schreiner
·
D.A. Davidson
UiPath price target raised to $17 from $15 at Evercore ISI
$17.00
(was $17.24)
Evercore ISI
UiPath price target raised to $15 from $14 at Mizuho
$15.00
(was $14.86)
Mizuho Securities
UiPath price target raised to $16 from $14 at Barclays
$16.00
(was $14.86)
Barclays
UiPath price target raised to $14 from $12 at Wells Fargo
$14.00
(was $14.86)
Michael Turrin
·
Wells Fargo
UiPath resumed at Neutral from Sell at UBS
$17.00
(was $15.03)
UBS
UiPath price target raised to $13 from $12.50 at BMO Capital
$13.00
(was $12.99)
Keith Bachman
·
BMO Capital
UiPath price target raised to $16 from $14 at Canaccord
$16.00
(was $12.49)
Kingsley Crane
·
Canaccord Genuity